APA (7th ed.) Citation

SA, R., Z, M., J, C., C, Y., M, A., BD, F., . . . L, C. (2025). High Frequency of Chronic Urticaria Following an Investigational HIV-1 BG505 MD39.3 Trimer mRNA Vaccine in a Phase 1, Randomized, Open-Label Clinical Trial (HVTN 302). Annals of internal medicine, 178(7), 963. https://doi.org/10.7326/ANNALS-24-02701

Chicago Style (17th ed.) Citation

SA, Riddler, et al. "High Frequency of Chronic Urticaria Following an Investigational HIV-1 BG505 MD39.3 Trimer MRNA Vaccine in a Phase 1, Randomized, Open-Label Clinical Trial (HVTN 302)." Annals of Internal Medicine 178, no. 7 (2025): 963. https://doi.org/10.7326/ANNALS-24-02701.

MLA (9th ed.) Citation

SA, Riddler, et al. "High Frequency of Chronic Urticaria Following an Investigational HIV-1 BG505 MD39.3 Trimer MRNA Vaccine in a Phase 1, Randomized, Open-Label Clinical Trial (HVTN 302)." Annals of Internal Medicine, vol. 178, no. 7, 2025, p. 963, https://doi.org/10.7326/ANNALS-24-02701.